Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMSP03010005 | C20 Sphingomyelin | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 29 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 37.7 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 24 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 31.1 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 38.6 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 38.8 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 32.5 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 34.7 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | C | 0.0 | BCD100322A01 | 29.1 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | C | 0.5 | BCD100322A03 | 28.6 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | C | 1.0 | BCD100322A07 | 29.8 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | C | 2.0 | BCD100322A11 | 32.8 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | C | 4.0 | BCD100322A15 | 33.9 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | C | 8.0 | BCD100322A19 | 37.8 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | C | 12.0 | BCD100322A23 | 41 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | C | 24.0 | BCD100322A27 | 32.7 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 34 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 34.6 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 37.3 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 36.8 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 37.8 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 44.8 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 38.8 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol | 0.5 | BCD100322A04 | 29 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol | 1.0 | BCD100322A08 | 26.8 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol | 2.0 | BCD100322A12 | 31.9 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol | 4.0 | BCD100322A16 | 38.5 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol | 8.0 | BCD100322A20 | 41.5 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol | 12.0 | BCD100322A24 | 37.6 | pmol/sample |
| LMSP03010005 | C20 Sphingomyelin | 25OH-Chol | 24.0 | BCD100322A28 | 37.1 | pmol/sample |